CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD)
|
|
- Griselda Beatrice Blake
- 5 years ago
- Views:
Transcription
1 CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD) DEFINITION A Patient Group Direction (PGD) is a specific written instruction for the supply and administration of a named medicine to a group of patients in an identified clinical situation. The majority of clinical care should be provided on an individual, patient specific basis. The supply and administration of medicines under PGD must therefore be reserved for those limited situations where they offer advantages for patient care without compromising patient safety. TARGET GROUP All health professionals employed by the Trust who are required to supply or administer medicines using PGDs as part of their role. TRAINING All staff in the Trust are required to comply with the Trust s Training Matrix which specifies mandatory training; in addition clinical staff are required to comply with their service level training matrix which outlines the training and competencies required for their specific role. A senior health professional within each service utilising PGDs is responsible for ensuring only qualified competent professionals use each PGD. Health professionals delivering care authorised by PGDs must be able to demonstrate to their senior colleague; an understanding of working within the limitations of the PGD, an understanding of the clinical condition(s) treated via the PGD and knowledge of the medicines authorised by the PGD. 1/6
2 LEGAL FRAMEWORK FOR PGD The current legislation for PGDs is outlined within The Human Medicines Regulations This legislation was amended in April 2013 to reflect changes in the NHS organisational structures in England. The original legislation establishing PGDs was Health Service Circular 2000/026 Healthcare organisations need to ensure that any current or new patient group directions comply with the legal requirements and guidance set out in the current regulations. Failure to comply with the legal requirements could result in a criminal prosecution under the Medicines Act. PEER REVIEW FOR PGDs The Trust s Group will oversee the development and updates of all PGDs. To ensure consistency in format there is a standard PGD layout for use within the Trust. All PGDs are updated after 3 years or earlier if clinical evidence based practice indicates a need for an earlier update The specialist lead in the service responsible for supporting updating the PGD must comply with the agreed time scales for the updating process If a PGD is not updated with the agreed time frame, this would need to be recorded on the service at risk register and an action put in place for its timely update PGD SAFETY CONCERNS Safety concerns must be a priority, notably: Security, storage and labelling arrangements must be in place for any medicine administered or issued via a PGD. Medicines supplied and taken away by the patient for self administration or administration by a carer must be labelled. In the majority of cases the medicine must be overlabelled by a licensed unit. In the case of oral contraceptives, original manufacturer s packs with dosing instructions can be supplied where the service adds the patient s name and date of supply. All medicines issued by PGDs should be labelled with the address of the supplying clinic. There must be secure recording and monitoring systems so that in-coming and outgoing stock may be reconciled on a patient-by-patient basis. Names of those providing treatment, patient identifiers and medicines provided must all be recorded. 2/6
3 Provision must comply with; section 20 regulations of the Health and Social Care Act and European Community Labelling and Leaflet directive 92/27. Medicine use must be consistent with their Summary of Product Characteristics and any relevant NHS guidance. DEVELOPING NEW PGDS WITHIN THE TRUST Approval from the Service Lead or Divisional Manager and the Trust s Medicines Management Group is needed before developing new PGDs. There must be an identified budget to meet costs of new PGDs. If there is no identified budget this should be discussed with the Director of Development prior to any further development taking place. Storage of medicines must comply with Trust Policy and section 20 regulations of the Health and Social Care Act Clinical expertise for developing PGDs will come from the service developing the PGD in partnership with a Trust Pharmacist. WHO CAN ADMINISTER FROM A PGD IN THE TRUST The qualified practitioners who may supply or administer medicines under a Patient Group Direction are Nurses, Midwives, Health Visitors, Optometrists, Pharmacists, Podiatrists, Physiotherapists, Dental Hygienists and Dental Therapists. They can only do so as named individuals. REQUIRED SIGNATURES FOR THE TRUST The Patient Group Directions must be signed by:- A senior trust pharmacist A senior doctor (or, if appropriate a dentist) A senior representative of the professional group expected to supply or administer medicines under the PGD (All of whom should have been involved in developing the direction.) Head of Nursing, Quality and Governance Responsibility for signing PGDs can be delegated e.g. in cases of prolonged absence SIGNATURES OF QUALIFIED PRACTITIONERS The individual qualified practitioners who are to follow the PGDs must sign to agree to comply with the PGD. In addition the signature of each individual practitioner must be countersigned by their line manager to confirm that the practitioner is fully competent, qualified and trained to 3/6
4 operate within the PGD. A copy of this must also be kept on file by the line manger. Overall responsibility for signatures of staff remains with the Service Lead or Divisional Manager. ANTIBIOTICS Particular caution must be exercised in any decision to draw up Patient Group Directions relating to antibiotics. A Wirral University Teaching Hospital Consultant Microbiologist must be involved in drawing up any such direction and the Trust Group must ensure that such directions are consistent with local policies and subject to regular review. WHAT CANNOT BE INCLUDED IN A PATIENT GROUP DIRECTION The following should not normally be included in a Patient Group Direction:- New drugs under intensive monitoring and subject to special adverse reaction reporting requirements [Black Triangle Scheme]. (except when such use is supported by national NHS guidance such as the Joint Committee on Vaccination and Immunisation) Medicines used outside their licensed indications (except when such use is supported by best clinical practice, e.g. NICE Guidance.) The following should never be included in a Patient Group Direction Medicines being used in clinical trials. Unlicensed medicines. MINIMUM CONTENTS OF A PATIENT GROUP DIRECTION The law specifies that each Patient Group Direction must contain the following: A description of the medicine(s) to which the direction applies. The clinical condition or situation to which the direction applies. A description of those patients included and those excluded from treatment under the direction. A description of the circumstances in which further advice should be sought from a doctor (or dentist, as appropriate) and arrangements for referral. Details of appropriate dosage and maximum total dosage, quantity, pharmaceutical form and strength, route and frequency of administration, and minimum or maximum period over which the medicine should be administered. Details of any necessary follow-up action and the circumstances. Relevant warnings, including potential adverse reactions. The date the direction comes into force and the date it expires. Class of health professional who may supply or administer the medicine. Signature of a doctor or dentist, as appropriate, and a pharmacist. Signature of the Trust s Clinical Governance lead. A statement of the records to be kept for audit purposes. Patient Group Directions should be reviewed at least every three years. 4/6
5 Further guidance is contained in The Human Medicines Regulations 2012 (Amended April 2013) UPDATING AND STORAGE OF PGDS PGDs are held electronically by the. The original signed copies are also held as controlled stationery. All PGDs are updated after 3 years or earlier if clinical evidence based practice indicates a need for an earlier update. Any changes require a reference source or rationale for change. Allow time to obtain necessary signatures to ensure PGD is valid and adheres to Department of Health guidance. Plan for practitioners signatures to be obtained for all those authorised to use the PGD, and for the signatures to be appropriately countersigned, keeping a copy on file. Paper/electronic copies of outdated PGDs must be kept on file for eight years, PGDs relating to children must be kept for 25 years, document control will be managed by the. HEALTH RECORDS Health records must be consistent with the Trust Health Records Policy and service procedures where appropriate It is essential that practitioners have a copy of the PGD to refer to when supplying or administering medication, this will ensure the practitioner will be able to check that all the conditions of the PGD are fully met for that individual. INCIDENT REPORTING Clinical incidents or near misses relating to this protocol must be reported using the Trust Incident Reporting System. EQUALITY ASSESSMENT During the development of this protocol the Trust has considered the clinical needs of each protected characteristic (age, disability, gender, gender reassignment, pregnancy and maternity, race, religion or belief, sexual orientation). There is no evidence of exclusion of these named groups. If staff become aware of any clinical exclusions that impact on the delivery of care, the incident must be reported using the Trust Incident Reporting System and an appropriate action plan put in place. REFERENCES NICE Guidance MPG2 Patient Group Directions August /6
6 European Community Labelling and Leaflet directive 92/27 Health and Social Care Act Health Service Circular 2000/026 Patient Group Directions (England only) CONTROL RECORD Title Clinical Protocol for the Development and Implementation of Patient Group Directions (PGD) Purpose The purpose of this clinical protocol is to support health professionals when developing, supplying or administering medicines via a PGD Author (QGS) Equality Assessment Integrated into protocol Yes No Subject Experts Lisa Knight Medicines Governance Pharmacist Document Librarian QGS Groups consulted with :- Group Infection Control Approved Not applicable Date formally approved by March 2015 Quality, Patient Experience and Risk Group Method of distribution Intranet Archived Date: Location: S Drive QGS Access Via QGS VERSION CONTROL RECORD Version Number Author Status Changes / Comments Version 1 Lisa Knight Annie Baker N To ensure support for all health Professionals who supply or administer medicines via a PGD Version 2 Lisa Knight R To reinforce the need for signatures of individual practitioners to be countersigned Version 3 Lisa Knight R To incorporate NICE guidance on PGDs Status New / Revised / Trust Change 6/6
STANDARD OPERATING PROCEDURE ADMINISTRATION OF HEPARIN FLUSHES VIA CENTRAL INTRAVENOUS ACCESS DEVICES
STANDARD OPERATING PROCEDURE ADMINISTRATION OF HEPARIN FLUSHES VIA CENTRAL INTRAVENOUS ACCESS DEVICES First Issued Issue Version One Purpose of Issue/ Description of Change To promote the safe administration
More informationSTANDARD OPERATING PROCEDURE THE TRANSPORTATION OF PRESCRIBED CONTROLLED DRUGS AND OTHER URGENTLY REQUIRED MEDICATION BY COMMUNITY NURSES
STANDARD OPERATING PROCEDURE THE TRANSPORTATION OF PRESCRIBED CONTROLLED DRUGS AND OTHER URGENTLY REQUIRED MEDICATION BY COMMUNITY NURSES Issue History Issue Version Purpose of Issue/Description of Change
More informationSTANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION.
STANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION. Issue History Oct 12 Issue Version Two Purpose of Issue/Description of Change To ensure implementation
More informationWitnessing the Destruction of Stock Controlled Drugs within Wirral Community Trust Services
STANDARD OPERATING PROCEDURE Witnessing the Destruction of Stock Controlled Drugs within Wirral Community Trust Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date One
More informationPGDs are permitted for use only by registered health professionals (see enclosed link for full list
NHS England North - Yorkshire and the Humber Region Protocol for the Development, Authorisation and Use of Patient Group Directions for the National Immunisation Programmes 1. Introduction The preferred
More informationPROTOCOL FOR UNIVERSAL ANTENATAL CONTACT (FOR USE BY HEALTH VISITING TEAMS)
Scope - CP12 PROTOCOL FOR UNIVERSAL ANTENATAL CONTACT (FOR USE BY HEALTH VISITING TEAMS) RATIONALE The Healthy Child Programme Pregnancy and the first five years of life (DH, 2009) states that health professionals,
More informationFOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING
STANDARD OPERATING PROCEDURE FOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING Issue History Issue Version One Purpose of Issue/Description of Change To promote safe and effective medicine administration
More informationPROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS
STANDARD OPERATING PROCEDURE PROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS Issue History Issue Version one Purpose of Issue/Description of Change To facilitate patients
More informationExpiry Date: January 2009 Template Version: Page 1 of 7
YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria: Cautions/Need for
More informationDocument Details. Patient Group Direction
Document Details Title Patient Group Direction (PGD) CO-CODAMOL 30/500 TABLETS FOR MINOR INJURIES UNITS Trust Ref No 1956-35206 Local Ref (optional) Main points the document treatment of moderate pain
More informationSAFE HANDLING OF PRESCRIPTION FORMS FOR DOCTORS AND DENTISTS
STANDARD OPERATING PROCEDURE SAFE HANDLING OF PRESCRIPTION FORMS FOR DOCTORS AND DENTISTS Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date One To ensure robust systems
More informationExpiry Date: January 2009 Template Version: Page 1 of 7
YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Patients who require an antihistamine
More informationSAFE HANDLING OF PRESCRIPTION FORMS FOR PRIMARY AND UNPLANNED CARE DIVISIONS
STANDARD OPERATING PROCEDURE SAFE HANDLING OF PRESCRIPTION FORMS FOR PRIMARY AND UNPLANNED CARE DIVISIONS Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date One To ensure
More informationDocument Details. notification of entry onto webpage
Document Details Title Patient Group Direction (PGD) Administration of sodium chloride 0.9% injection by registered professionals Trust Ref No 1987-38096 Local Ref (optional) Main points the document As
More informationSupply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 2
Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 2 Date protocol prepared: October 2017 Date protocol due for review: October 2019 Expiry date: October
More informationCLINICAL PROTOCOL FOR THE IDENTIFICATION OF SERVICE USERS
CLINICAL PROTOCOL FOR THE IDENTIFICATION OF SERVICE USERS RATIONALE All Professionals/healthcare workers are personally accountable for their practice and, in the exercise of their professional accountability,
More informationSupply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 1
Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 Date protocol prepared: December 2015 Date protocol due for review: December 2017 This patient group direction
More informationNON-MEDICAL PRESCRIBING POLICY
NON-MEDICAL PRESCRIBING POLICY To be read in conjunction with the Medicines Policy, Controlled Drug Policy and the FP10 Prescribing Forms Policy Version: 5 Date of issue: August 2017 Review date: August
More informationSupply of Fusidic Acid Cream 2% by Community Pharmacists for the treatment of impetigo in patients 2 years of age and over.
Supply of Fusidic Acid Cream 2% by Community Pharmacists for the treatment of impetigo in patients 2 years of age and over. November 2017 Review Nov 2019 Signatures of those developing the Patient Group
More informationPROCEDURE FOR IMMUNISATION
Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date One To promote the safe administration of vaccines 2014 Named Responsible Officer:- Approved by Date Medicines Governance
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Unlicensed Medicines Policy
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Unlicensed Medicines Policy Version.: 2.4 Effective From: 13 October 2016 Expiry Date: 13 October 2018 Date Ratified: 12 October 2016 Ratified By:
More informationNon-Medical Prescribing Passport. Reflective Log And Information
Non-Medical Prescribing Passport Reflective Log And Information Non-Medical Prescribing Continued Profession Development Log NMPs must refer to their regulatory bodies requirements for maintaining and
More informationName Job Title Signed Date. This Patient Group Direction is operational from: Oct 2017 Review date: Aug 19. Expires on 31 st October 2019
PGD4017 PATIENT GROUP DIRECTION FOR THE SUPPLY OF ACICLOVIR TABLETS FOR THE TREATMENT OF GENITAL HERPES SIMPLEX INFECTIONS by registered nurses and midwives in Integrated Sexual Health services employed
More informationPatient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders.
Patient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders. This document authorises the supply of Fusidic Acid Cream 2% by registered
More informationCLINICAL PROTOCOL FOR COMMUNITY PODIATRY PATIENTS WITH TYPE II DIABETES
CLINICAL PROTOCOL FOR COMMUNITY PODIATRY PATIENTS WITH TYPE II DIABETES RATIONALE Access to Community Podiatry services and treatment intervals for Diabetic patients, will generally be determined by the
More informationHealth & Safety Policy. Author:
Title: Reference No: Owner: Author: Health & Safety Policy 0010/Corporate Chief Officer Competent Person for Health and Safety Ruth Nutbrown CMIOSH First Issued On: Governing Body 4 December 2013 Latest
More informationPatient Group Direction (PGD) template
Patient Group Direction (PGD) template Initial supply of doxycycline 100mg capsules to adults and children aged eight (8) years and over exposed to a suspected biological agent Version no: 2014/2 Valid
More informationNHS Fife. Patient Group Direction for Named Community Pharmacists to Supply
Patient Group Direction for Named Community Pharmacists to Supply Senna tablets 7.5mg or Senna syrup 7.5mg/5ml (Total sennosides calculated as sennoside B) For patients aged 16 years and older prescribed
More informationPROCEDURE FOR TAKING A WOUND SWAB
CLINICAL PROCEDURE PROCEDURE FOR TAKING A WOUND SWAB Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date 2 To provide a standardised process of the fundamental principles
More informationPARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
PARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its
More informationPatient Group Direction Policy
Approval Process Patient Group Direction Policy Lead Author Developed by Sarah Woodley, Community Health Services Pharmacist 01223 474903 sarah.woodley@cambridgeshirepct.nhs.uk Sarah Woodley, Gillian Ascough,
More informationIBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its
More informationBest Practice Statement ~ March Patient Group Directions
Best Practice Statement ~ March 2006 Patient Group Directions NHS Quality Improvement Scotland 2005 ISBN 1-84404-403-3 First published March 2006 NHS Quality Improvement Scotland (NHS QIS) consents to
More informationAll areas of the Trust All Trust staff All Patients Deputy Chief Nurse & Chief Pharmacist Final
Trust Policy and Procedure Document Ref. No: PP(15)233 Non-Medical Prescribing Policy For use in: For use by: For use for: Document owner: Status: All areas of the Trust All Trust staff All Patients Deputy
More informationPATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OF DOXYCYCLINE 100MG CAPSULES / TABLETS FOR THE FIRST- LINE TREATMENT OF CHLAMYDIA TRACHOMATIS INFECTION
This Patient Group Direction () must only be used by registered pharmacists who have been named and authorised by their organisation to practice under it. The most recent and in date final signed version
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Access to Drugs Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Access to Drugs Policy Version No.: 3.0 Effective From: 25 January 2016 Expiry Date: 25 January 2019 Date Ratified: 4 November 2015 Ratified By: Medicines
More informationMedicines Optimisation Strategy
Medicines Optimisation Strategy 2014-2017 Contents Section Page 1 Foreword 3 2 Strategic Principles for Medicines Optimisation 4 3 Introduction 4 4 Trust Vision and Values 5 5 Strategy Development 5 6
More informationGG&C PGD ref no: 2011/841 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2011/841 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria:
More informationGG&C PGD ref no: 2017/1426 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2017/1426 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Immunisation
More informationJOB DESCRIPTION. 1 year fixed term. Division A Pharmacy. University Hospitals Birmingham. Advanced Clinical Pharmacist Trials.
JOB DESCRIPTION JOB TITLE: Pharmacy Technician Haematology Clinical Trials PAY BAND: Agenda for change - Band 5 TERMS AND CONDITIONS DEPARTMENT/DIVISION: BASED AT: REPORTS TO: PROFESSIONALLY RESPONSIBLE
More informationNON MEDICAL PRESCRIBING POLICY
NON MEDICAL PRESCRIBING POLICY Document Summary This Policy provides the framework and standards for Non-Medical Prescribing. The application of this policy will ensure that all non-medical prescribers
More informationNon Medical Prescribing Policy Register No: Status: Public
Non Medical Prescribing Policy Policy Register No: 07049 Status: Public Developed in response to: Department of Health Policies, Prescribing Guidance & Legislation Contributes to CQC Outcome: 9 Consulted
More informationPOLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case
POLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case DOCUMENT NO: DN116 Lead author/initiator(s): Sarah Woodley Community Health Services Pharmacist sarah.woodley@ccs.nhs.uk
More informationMedical Needs Policy. Policy Date: March 2017
Medical Needs Policy Policy Date: March 2017 Renewal Date: March 2017 Equality Statement This policy takes into account the provisions of the Equality Act 2010 and advances equal opportunities for all.
More informationUnlicensed Medicines Policy Document
Unlicensed Medicines Policy Document Effective: February 2002 (Intranet 2006) Review date: February 2007 A. Introduction In order to ensure that medicines are safe and effective the manufacture and sale
More informationSection Title. Prescribing competency framework Catherine Picton, Lead author
Prescribing competency framework Catherine Picton, Lead author What is in this presentation Context Uses of the competency framework Scope of the updated prescribing competency framework Introduction to
More informationPHARMACEUTICAL REPRESENTATIVE POLICY NOVEMBER This policy supersedes all previous policies for Medical Representatives
PHARMACEUTICAL REPRESENTATIVE POLICY VEMBER 2017 This policy supersedes all previous policies for Medical Representatives Policy title Pharmaceutical Representative Policy Policy PHA39 reference Policy
More informationCLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical
More informationName Job Title Signed Date
PGD3517 PATIENT GROUP DIRECTION FOR THE SUPPLY OF AZITHROMYCIN TABS/CAPS 250mg or TABS 500mg OR SUSPENSION 600mg/15mL FOR UNCOMPLICATED GENITAL CHLAMYDIA TRACHOMATIS, UNCOMPLICATED NEISSERIA GONORRHOEA
More informationTHE TREATMENT OF BACTERIAL VAGINOSIS (BV) OR TRICHOMONAS VAGINALIS
PGD3717 PATIENT GROUP DIRECTION FOR THESUPPLY OF METRONIDAZOLE 400mg TABLETSFOR THE TREATMENT OF BACTERIAL VAGINOSIS (BV) OR TRICHOMONAS VAGINALIS (TV) by registered nurses and midwives in Integrated Sexual
More informationDocument Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026
Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Version: 1.1 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department:
More informationHepatitis B Immunisation procedure SOP
Hepatitis B Immunisation Procedure SOP Standard Operating Procedure (SOP) Ref No: 1992 Version: 3 Prepared by: Karen Bennett Presented to: Care and Clinical Policies Sub Group Ratified by: Care and Clinical
More informationPATIENT GROUP DIRECTION
PATIENT GROUP DIRECTION FOR THE SUPPLY OF FUSIDIC ACID CREAM 2% FOR THE TREATMENT OF IMPETIGO BY COMMUNITY PHARMACISTS UNDER THE PHARMACY FIRST SERVICE IN NHS HIGHLAND THE COMMUNITY PHARMACIST SEEKING
More informationCCG: CO01 Access and Choice Policy
Corporate CCG: CO01 Access and Choice Policy Version Number Date Issued Review Date V2 21 January 2016 January 2018 Prepared By: Consultation Process: NECS Commissioning Manager CCG Head of Corporate Affairs.
More informationJob Title Name Signature Date
Supply of Fluconazole 150mg capsule by Community Pharmacists working in Forth Valley Pharmacies under NHS Minor Ailment Service. Protocol Number 125 Version 5 Date protocol prepared: November 2014 Date
More informationTexas Administrative Code
RULE 19.1501 Pharmacy Services A licensed-only facility must assist the resident in obtaining routine drugs and biologicals and make emergency drugs readily available, or obtain them under an agreement
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Strong Potassium Solutions Safe Handling and Storage
The Newcastle upon Tyne Hospitals NHS Foundation Trust Strong Potassium Solutions Safe Handling and Storage Version : 5.3 Effective From: 19 January 2016 Expiry Date: 19 January 2019 Date Ratified: 14
More informationUnlicensed Medicines Policy
Unlicensed Medicines Policy This procedural document supersedes: PAT/MM 4 v.3 Policy and Procedure for the Use of Unlicensed Medicines Did you print this document yourself? The Trust discourages the retention
More informationNon Medical Prescribing Policy
Non Medical Prescribing Policy Author: Sponsor/Executive: Responsible committee: Ratified by: Consultation & Approval: (Committee/Groups which signed off the policy, including date) This document replaces:
More informationNHS Lothian Patient Group Direction Version: 001
PATIENT GROUP DIRECTION FOR THE SUPPLY OF FUSIDIC ACID CREAM 2% TO TREAT MINOR STAPHYLOCOCCAL SKIN INFECTIONS (IMPETIGO) IN PATIENTS AGED OVER 2 YEARS BY PHARMACISTS WORKING WITHIN NHS LOTHIAN COMMUNITY
More informationPatient Group Direction For the supply of Fusidic Acid 2% Cream
Patient Group Direction For the supply of Fusidic Acid 2% Cream This Patient Group Direction (PGD) is a specific written instruction for the supply of Fusidic Acid 2% Cream to groups of patients who may
More informationGG&C PGD ref no: 2018/1562 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2018/1562 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: For active immunisation in adults
More informationNHS and LA Reforms Factsheet 5
NHS and LA Reforms Factsheet 5 Supply of medicines for public health commissioned services a factsheet for local authorities 1. Introduction As of April 2013, local authorities have responsibility for
More informationPatient Group Direction for ACICLOVIR (Version 02) Valid From 1 October September 2019
Version Control This PGD has been agreed by the following organisations FCMS PDS Medical Doncaster CCG Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire CCGs Change history
More informationDocument Title: Document Number:
including Document Title: Document Number: Version: 2.0 Ratified by: Committee Date ratified: 25/01/2018 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel Fay Corporate
More informationHealth and Safety Strategy
NHS Newcastle Gateshead Clinical Commissioning Group Health and Safety Strategy Document Status Equality Impact Assessment Document Ratified/Approved By Final No impact Quality, Safety and Risk Committee
More informationPHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK
PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK 0 CONTENTS Course Description Period of Learning in Practice Summary of Competencies Guide to Assessing Competencies Page 2 3 10 14 Course
More informationProcess and methods Published: 23 January 2017 nice.org.uk/process/pmg31
Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationADMINISTRATION OF MEDICATION POLICY G&F ALTERNATIVE PROVISION SCHOOL
Gloucester & Forest Alternative Provision School ADMINISTRATION OF MEDICATION POLICY G&F ALTERNATIVE PROVISION SCHOOL Date:September 2013 PURPOSE The guidance in this policy is to ensure that pupils with
More informationBirmingham, Sandwell and Solihull Eligibility Criteria Policy for NHS Non-Emergency Patient Transport (NEPT)
Birmingham, Sandwell and Solihull Eligibility Criteria Policy for NHS Non-Emergency Patient Transport (NEPT) Version: 0.1 Ratified by: Date ratified: 1 st June 2016 Name of originator/author: Name of responsible
More informationPatient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019
THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: CLINICAL COMMISSIONING GROUP: Doncaster CCG, Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire
More informationNOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST MEDICINES CODE OF PRACTICE MEDICINES MANAGEMENT WHEN PATIENTS ARE DISCHARGED FROM HOSPITAL
NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST MEDICINES CODE OF PRACTICE MEDICINES MANAGEMENT WHEN PATIENTS ARE DISCHARGED FROM HOSPITAL Reference CL/MM/024 Date approved 13 Approving Body Directors Group
More informationDiagnostic Test Reporting & Acknowledgement Procedures. - Pathology & Clinical Imaging
Diagnostic Test Reporting & Acknowledgement Procedures V2.0 November 2014 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5.
More informationPROCEDURE FOR CHECKING THE WATER IN BALLOON RETAINED GASTROSTOMY TUBE / LOW PROFILE DEVICES FOR BOTH ADULTS AND CHILDREN
PROCEDURE FOR CHECKING THE WATER IN BALLOON RETAINED GASTROSTOMY TUBE / LOW PROFILE DEVICES FOR BOTH ADULTS AND CHILDREN First Issued Issue Version Purpose of Issue/Description of Change Planned Review
More informationDispensing Medications Practice Standard
October 2013 Updated December 8, 2016 s set out baseline requirements for specific aspects of Registered Psychiatric Nurses practice. They interact with other requirements such as the Code of Ethics, the
More informationPatient Group Directions December A practical guide and framework of competencies for all professionals using patient group directions
Patient Group Directions December 2009 A practical guide and framework of competencies for all professionals using patient group directions Acknowledgements Editors Contributors John Wright Business Manager
More informationSpecialised Services: CPL-008 Referral Management Policy
Specialised Services: CPL-008 Referral Management Policy 2017 Version 2.0 Document information Document purpose Document name Policy Referral Management Policy Author Welsh Health Specialised Services
More informationCARE FACILITIES PART 300 SKILLED NURSING AND INTERMEDIATE CARE FACILITIES CODE SECTION MEDICATION POLICIES AND PROCEDURES
TITLE 77: PUBLIC HEALTH CHAPTER I: DEPARTMENT OF PUBLIC HEALTH SUBCHAPTER c: LONG-TERM CARE FACILITIES PART 300 SKILLED NURSING AND INTERMEDIATE CARE FACILITIES CODE SECTION 300.1610 MEDICATION POLICIES
More informationNHS North Somerset Clinical Commissioning Group
NHS North Somerset Clinical Commissioning Group Medicines Policy - Safe and Secure Handling of Medicines Approved by: Quality and Assurance Group Ratification date: July 2013 Review date: June 2016 Page
More informationDocument Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator
including Roles and Responsibilities for the Conduct of Research Studies and Clinical Trials including CTIMPs (Clinical Trials of Investigational Medicinal Products) Document Number: 006 Version: 1 Ratified
More informationCentral Alerting System (CAS) Policy
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified By Central Alerting System (CAS) Policy NTW(O)17 Gary O Hare Executive Director of Nursing and Operations Tony Gray
More informationLoading Dose Worksheet for Oral Amiodarone
This applies to adult patients only Key: General Notes ED/MAU/SRU/Acute GP/Amb-Care GP/SWASFT In-patient wards Start Prescribe as per loading dose worksheet below End 1. Aim/Purpose of this Guideline 1.1.
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Introduction and Development of New Clinical Interventional Procedures
The Newcastle upon Tyne Hospitals NHS Foundation Trust Introduction and Development of New Clinical Interventional Procedures Version No.: 2.1 Effective From: 27 November 2017 Expiry Date: 7 January 2019
More informationMEDICINES POLICY. All staff working within the Trust who are involved in any way with the use of medicines. This includes locum and agency staff.
MEDICINES POLICY To be read in conjunction with: Antimicrobial Prescribing Policy; Clozapine Policy, Controlled Drugs Policy (see also section 28.2), and Medical Gases Policy. Version: 10 Date issued:
More informationPROCEDURE FOR RECORD KEEPING FOR HEALTH VISITING
PROCEDURE FOR RECORD KEEPING FOR HEALTH VISITING Issue History Issue Version One Purpose of Issue/Description of Change Planned Review Date To promote safe and effective record keeping for all staff working
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Strategy for Non-Medical Prescribing
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Strategy for Non-Medical Prescribing Version No: 2.2 Effective From: 19 October 2016 Expiry Date: 19 October 2019 Date Ratified: 12 October 2016 Ratified
More informationDocument Title: File Notes. Document Number: 024
Document Title: File Notes Document Number: 024 Version: 1.2 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel
More informationJOB DESCRIPTION. 2. To participate in the delivery of medicines administration depending on local need and priorities.
JOB DESCRIPTION JOB TITLE: Clinical Pharmacy Technician PAY BAND: 5 DEPARTMENT/DIVISION: BASED AT: REPORTS TO: PHARMACY/A5 University Hospitals Birmingham Pharmacy Support Manager PROFESSIONALLY RESPONSIBLE
More informationPolicies, Procedures, Guidelines and Protocols
Policies, Procedures, Guidelines and Protocols Title Trust Ref No 1549-36354 Local Ref (optional) Main points the document covers Who is the document aimed at? Author Approval process Document Details
More informationA list of authorised referrers will be retained by the Colposcopy team and the Clinical Imaging Department.
Clinical Guideline for Clinical Imaging Referral Protocol for Nurse Colposcopist within Colposcopy Dept. Royal Cornwall Hospital 1. Aim/Purpose of this Guideline 1.1 This protocol applies to Nurse Colposcopist
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Water Safety Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Water Safety Policy Version No.: 2.0 Effective From: 09 February 2018 Expiry Date: 09 February 2021 Date Ratified: 09 November 2017 Ratified By: Infection
More informationSchool Vision Screening Policy V2.0
School Vision Screening Policy V2.0 05 April 2016 Summary. Vision screening test in school PASS Visual acuity LogMAR 0.2 both eyes Kays 0.1 both eyes Outcome letter sent home Test result information put
More informationSocial care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1
Managing medicines in care homes Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationHealth and Safety Policy
Health and Safety Policy NHS Leeds rth Clinical Commissioning Group NHS Leeds South and East Clinical Commissioning Group NHS Leeds West Clinical Commissioning Group Version: 2.1 Ratified by: NHS Leeds
More informationUncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES
Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE SECTION 9(a) UNLICENSED MEDICINES BACKGROUND and PURPOSE Under the Medicines Act 1968 (EEC Directive 65/65), a company
More informationSouth East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide
South East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide 1. Introduction 1.1 This policy has been developed by the South East London Clinical Commissioning
More informationDocument Title: Recruiting Process. Document Number: 011
Document Title: Recruiting Process Document Number: 011 Version: 1.0 Ratified by: Committee Date ratified: 24.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationxrfslt \j,3 0+ {6^1 Otc(L!?i:lr+ NHS FIFE PRIMARY CARE THIS PATIENT GROUP DIRECTION HAS BEEN APPROVED BY:
NHS FIFE PRIMARY CARE Patient Group Direction for Named Nurses in Contraception and Sexual Health Clinics to Supply Clotrim azole lo/o cream TO WOMEN CLIENTS for use in the treatment of vaginal candidiasis
More informationDocument Title: Research Database Application (ReDA) Document Number: 043
Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1 Ratified by: Committee Date ratified: 30 September 2014 Name of originator/author: Directorate: Department: Name of
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Medicines Reconciliation Policy and Procedure for Adult and Paediatric Patients
The Newcastle upon Tyne Hospitals NHS Foundation Trust Medicines Reconciliation Policy and Procedure for Adult and Paediatric Patients Version.: 2.0 Effective From: 15 March 2018 Expiry Date: 15 March
More information